mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
-0.0078 |
0.9 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
mRNA |
KIN001-260 |
GDSC1000 |
pan-cancer |
AAC |
0.0047 |
0.9 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.9 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.9 |